Previously treated cases tested for RR-/MDR-TB (%)

Name: Previously treated cases tested for RR-/MDR-TB (%)
Creator: WHO

Last updated time

11/11/2025 17:24

Source name

Indicator

Previously treated cases tested for RR-/MDR-TB (%)

Country/Region

China, Hong Kong Special Administrative Region

20052024

Testing previously treated drug-resistant TB by country in 2024 (previously treated cases tested for RR-/MDR-TB (%))

In 2024, Kazakhstan had the highest value (100) among 158 countries.

#	Country	Value	Change
1	Kazakhstan	100	0.0%
1	Afghanistan	100	0.0%
1	Albania	100	0.0%
1	Jordan	100	+78.6%
1	Benin	100	0.0%
1	Bangladesh	100	+17.6%
1	Bahrain (2023)	100	0.0%
1	Armenia	100	0.0%
1	Antigua and Barbuda (2022)	100	–
1	Jamaica (2023)	100	–
1	Barbados (2020)	100	–
1	Brunei Darussalam	100	0.0%
1	Bhutan	100	0.0%
1	Cote d'Ivoire	100	+8.7%
1	Cameroon (2023)	100	+4.2%
1	Congo	100	0.0%
1	Bahamas (2020)	100	0.0%
1	Comoros	100	0.0%
1	Cyprus (2023)	100	0.0%
1	Belarus	100	0.0%
1	Belize	100	0.0%
1	Eritrea	100	0.0%
1	Fiji	100	0.0%
1	Micronesia (Federated States of)	100	0.0%
1	Ghana	100	0.0%
1	Gambia	100	0.0%
1	Grenada (2023)	100	–
1	Iraq	100	0.0%
1	Iceland (2022)	100	+100.0%
1	Israel	100	0.0%
1	Republic of Korea	100	0.0%